:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Dawn C. Buse, Fumihiko Sakai, Manjit Matharu, Michael L. Reed, Kristina Fanning, Brett Dabruzzo, Richard B. Lipton
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Headache: The Journal of Head and Face Pain
Online Access:	https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14721
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prevalence and burden of migraine in the United States: A systematic review
by: Fred Cohen, et al.
Published: (2024)

What a long strange trip it's been: Reflections on serial snapshots of migraine prevalence and burden in the United States
by: Fred Cohen, et al.
Published: (2025)

Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings
by: Fred Cohen, et al.
Published: (2024)

Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi‐source dataset, observational cohort study
by: Dawn C. Buse, et al.
Published: (2026)

Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3‐Month results from the TRIUMPH study
by: Shivang Joshi, et al.
Published: (2026)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
by: Jessica Ailani, et al.
Published: (2024)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
by: Susan Hutchinson, et al.
Published: (2026)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
by: Rikki Mangrum, et al.
Published: (2024)

Comparative analysis of real‐world acute prescription migraine therapy outcomes: Insights from the HeAD – US study
by: Devin Teichrow, et al.
Published: (2026)

Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
by: Jonathan R. Treadwell, et al.
Published: (2025)

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study
by: Dawn C. Buse, et al.
Published: (2025)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
by: David Kudrow, et al.
Published: (2025)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
by: Richard B. Lipton, et al.
Published: (2025)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
by: Lawrence C. Newman, et al.
Published: (2025)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
by: Jessica Ailani, et al.
Published: (2026)

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
by: Nathaniel M. Schuster, et al.
Published: (2025)

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study
by: Richard B. Lipton, et al.
Published: (2025)

Low‐dose psilocybin in short‐lasting unilateral neuralgiform headache attacks: results from an open‐label phase Ib ascending dose study
by: James Rucker, et al.
Published: (2024)

Integrating gepants into clinical practice for the acute treatment of migraine
by: Richard B. Lipton, et al.
Published: (2026)

Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program
by: Idris Demirsoy, et al.
Published: (2025)

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
by: Koichi Ikeda, et al.
Published: (2025)

Development of the Migraine‐Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study
by: Elizabeth K. Seng, et al.
Published: (2025)

A retrospective analysis of the use of candesartan for migraine prevention in adolescents
by: Irene Patniyot, et al.
Published: (2024)

Combination behavioral and pharmacological interventions through telehealth platforms: Opportunities for increasing access and optimizing migraine outcomes
by: Teshamae S. Monteith, et al.
Published: (2025)

Effectiveness and acceptability of oral migraine preventives: A prospective, observational study
by: Hedda S. Riise, et al.
Published: (2026)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
by: Chia‐Chun Chiang, et al.
Published: (2024)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
by: Kara S. Graves, et al.
Published: (2026)

Do antithrombotic drugs have a role in migraine prevention? A systematic review
by: Federico De Santis, et al.
Published: (2025)

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
by: Richard B. Lipton, et al.
Published: (2025)

Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment
by: Joanna K. Bougie, et al.
Published: (2024)

Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
by: Anna Gryglas‐Dworak, et al.
Published: (2024)

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
by: Stephen D. Silberstein, et al.
Published: (2024)

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study
by: Julia Peris‐Subiza, et al.
Published: (2025)

Randomized controlled trial of intravenous dexamethasone to prevent relapse in the treatment of migraine in a pediatric emergency department
by: Geneviève Tourigny‐Ruel, et al.
Published: (2026)

Response to: Disagreement with Categorization of Clinical Trials included in Treadwell et al. Systematic Review and Meta‐Analysis
by: Jonathan R. Treadwell, et al.
Published: (2025)

Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
by: Emmanuelle A. D. Schindler, et al.
Published: (2025)

Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society
by: Todd J. Schwedt, et al.
Published: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
by: Graham A. McLeod, et al.
Published: (2025)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
by: Yunus Emre Meydanal, et al.
Published: (2025)

Reliability, validity, and responsiveness of the Arabic version of HIT ‐6 questionnaire in patients with migraine indicated for preventive therapy: A multi‐center study
by: Mona Hussein, et al.
Published: (2024)